Brief: Alimera Sciences Announces Q3 Financial Results
Nov 14 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA SCIENCES ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
* QTRLY LOSS PER SHARE $0.75
* QTRLY CONSOLIDATED NET PRODUCT REVENUE OF $13.6 MILLION,
UP 11%
VERSUS Q3 OF 2021
* ON SEPTEMBER 30, 2022, ALIMERA HAD CASH AND CASH
EQUIVALENTS OF
APPROXIMATELY $5.5 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.40, REVENUE VIEW $15.2
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2xz1MM
Further company coverage: ALIM.O
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger